Sleep Apnea Devices Market Synopsis

The global Sleep Apnea Devices Market was valued at USD 5.9 billion in 2023 and is likely to reach USD 10.43 billion by 2032, increasing at a CAGR of 6.53% from 2024 to 2032.

Sleep apnea is a disorder that affects the upper airway, causes bouts of shallow breathing, or recurrently stops breathing during sleep. This results in insufficient ventilation and disrupts sleep patterns.

  • There are two types of sleep apnea: central sleep apnea (CSA), which causes regular breathing to stop involuntarily, and obstructive sleep apnea (OSA), which causes airflow to be impeded. OSA is the most common kind.
  • Obstructive sleep apnea (OSA), if left untreated, is a serious medical disorder that can have systemic effects. Patients who do not receive effective therapy for their OSA are at a higher risk of dying from cardiovascular problems. Hypertension, atrial fibrillation, congestive heart failure, coronary artery disease, stroke, and type 2 diabetes are further problems.
  • This graph depicts the sleep apnea therapeutics and diagnostics market size worldwide since 2020, with projections up to 2023. Sleep apnea is a medical condition at which the patient’s breathing patterns during sleep decrease or even stop.

Sleep Apnea Devices Market Trend Analysis

Growing Demand for Efficient Treatment Alternatives

  • Growing demand for effective treatment options, an increase in the prevalence of risk factors like obesity and aging populations, increased awareness and diagnosis of sleep disorders, and advancements in therapeutic and diagnostic device technology are driving the market for sleep apnea.
  • Healthcare laws that encourage the early detection and treatment of sleep apnea are another factor driving market growth. Modern lifestyle changes, obesity rates rising, and aging populations have all led to an increase in sleep problems.
  • Thus, there is a greater need than ever for technologically sophisticated, adaptable, and efficient technology. In commercialized devices, oral devices are becoming a common replacement for conventional positive airway pressure devices.

Opportunities

Technology Advancements using AI

  • Sleep apnea devices with smart technology can change how they work for each person. They use AI to adjust how they help you while you sleep. They check your data all the time to make sure you're getting the best treatment and feeling comfortable.
  • Smart machines can notice when your breathing changes and adjust how much air you need. This makes sure you're getting the right help all through the night.
  • Some gadgets you can wear, like smartwatches, can spot sleep apnea early on. They use special sensors to watch your sleep and tell if you're having trouble breathing.
  • There are special mouthpieces for moderate cases of sleep apnea. They're made just for you using 3D printing, so they're comfortable. Some even have sensors to check if they're helping you sleep better.
  • Some devices you can put inside your body help treat sleep apnea. They're put in with very small cuts. They work by sending signals to certain muscles or nerves to keep your airway open when you sleep. Scientists are still working on making them even better and safer for the long term.

Market Segment Analysis:

Market Segmented based on Type, Treatment, End User, And Region

By Type, Obstructive Sleep Apnea Segment Is Expected to Dominate the Market During the Forecast Period

There are three segmentations by type obstructive sleep apnea(OSA), central and complex but obstructive sleep apnea is more common.

  • Because of the tongue and soft palate rattling, OSA can cause snoring. Additionally, it may make someone feel as though they are gasping for air when they wake up. The body attempts to breathe despite the obstruction of the upper airway, even while the lungs function normally.
  • OSA is becoming a more prevalent trusted source with advancing age and is more common in men, overweight individuals, expectant mothers, and back sleepers.
  • Among the symptoms are, being extremely fatigued when awake or waking up during the night, waking up in a panic, snoring or having trouble breathing while asleep, having frequent headaches, dry mouth at awakening feeling disoriented or unable to focus at work or school.

By Treatment, Continuous Positive Airway Pressure (CPAP) Segment Held the Largest Share

By Treatment, there are many segmentations CPAP, Surgery, Oral Appliances, and Medications but CPAP is the most dominant treatment.

  • CPAP therapy stands as the foremost treatment for sleep apnea, particularly for moderate to severe cases of obstructive sleep apnea (OSA), considered the standard of care. It involves wearing a mask linked to a machine that delivers a constant airflow, preventing airway collapse during sleep.
  • While CPAP is often the first choice, there are other options if someone can't use it or prefers something else. These include surgery, mouthpieces, and medications. However, CPAP is still the most commonly suggested and effective treatment for sleep apnea, especially if other treatments don't help enough.

Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast Period

  • In 2023, the market was led by the North American region in terms of share. Changing lifestyles, increasing disposable income, the presence of well-known players, an increase in the number of obese people, a rise in the incidence of respiratory illnesses, a rise in OSA awareness, and supportive government initiatives are some of the key factors contributing to the expansion.
  • Among the leading companies in North America are ResMed, Somnetics International Inc., and Philips Respironics. These companies are well-established in the market and have solid supply and distribution networks throughout North America.

Market Top Key Players:

  • The key companies in the Global Sleep Apnea Devices Market are:
  • Respironics (United States)
  • Fisher & Paykel Healthcare (New Zealand)
  • DeVilbiss Healthcare (United States)
  • Koninklijke Philips (Netherlands)
  • ResMed (United States)
  • Oventus (Australia)
  • SomnoMed (Australia)
  • Vivos Therapeutics (United States)
  • WholeYou (United States)
  • BMC Medical Co., Ltd. (China)
  • Weinmann Medical Technology (Germany)
  • Apex Medical Corp. (Taiwan)
  • Compumedics Limited (Australia)
  • Braebon Medical Corporation (Canada)
  • Cadwell Industries, Inc. (United States)
  • ImThera Medical (United States)
  • Inspire Medical Systems (United States)
  • Löwenstein Medical (Germany)
  • Nihon Kohden Corporation (Japan)
  • Itamar Medical Ltd. (Israel)
  • Teleflex Incorporated (United States)
  • Vyaire Medical (United States)
  • Circadiance (United States)
  • Airing (United States)
  • Sleepnet Corporation (United States)
  • Zephyr Sleep Technologies (Canada)
  • Oventus Medical (Australia)
  • Airway Management Inc. (United States)
  • Provent Sleep Therapy (United States)
  • NightBalance (Netherlands)
  • Sefam Group (France) and Other Major Players

Key Industry Developments In The Market:

  • Jan 2024, Phillips Agrees to stop selling sleep apnea machines in the United States, amid recall crisis, Philips has declared that it would no longer provide its CPAP and BiPAP sleep apnea appliances for sale in the US. This decision comes after numerous setbacks, including the Philips CPAP recalls and hundreds of court challenges, as well as a deal with the Food and Drug Administration
  • Feb 2024, ResMed launches new bi-level sleep apnea device, SAN DIEGO, February 12, 2024, ResMed (NYSE: RMD, ASX: RMD) launched today its AirCurve 11 series devices, the company's newest bilevel devices that employ expiratory positive airway pressure (EPAP) and inspiratory positive airway pressure (IPAP) as two degrees of support

Global Sleep Apnea Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017-2023

Market Size In 2023:

USD 5.9 Bn

Forecast Period 2024-32 CAGR:

6.53%

Market Size In 2032:

USD 10.43 Bn

Segments Covered:

By Type

  • Obstructive Sleep Apnea
  • Central Sleep Apnea
  • Complex Sleep Apnea

By Treatment

  • CPAP
  • Surgery
  • Oral Applications
  • Medications

By End-User

  • Hospitals/Clinics
  • Ambulatory Care Centre
  • Diagnostic Centres
  • Specialty Care Centres
  • Home Healthcare

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest Of Eastern Europe)
  • Western Europe (Germany, Uk, France, Netherlands, Italy, Russia, Spain, Rest Of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest Of Apac)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, Uae, Israel, South Africa)
  • South America (Brazil, Argentina, Rest Of Sa)

Key Market Drivers:

  • Growing Demand for Efficient Treatment Alternatives

Key Market Restraints:

  • Affordability Concern for Expensive Healthcare Devices

Key Opportunities:

  • Shift Toward Home-Based Sleep Testing and Treatment

Companies Covered In The Report:

  • Resmed, Philips, Respironics, Oventus, And Other Major Players
  1. INTRODUCTION
    1. RESEARCH OBJECTIVES
    2. RESEARCH METHODOLOGY
    3. RESEARCH PROCESS
    4. SCOPE AND COVERAGE
      1. Market Definition
      2. Key Questions Answered
    5. MARKET SEGMENTATION
  2. EXECUTIVE SUMMARY
  3. MARKET OVERVIEW
  4. GROWTH OPPORTUNITIES BY SEGMENT
  5. MARKET LANDSCAPE
    1. PORTER’S FIVE FORCES ANALYSIS
      1. Bargaining Power Of Supplier
      2. Threat Of New Entrants
      3. Threat Of Substitutes
      4. Competitive Rivalry
      5. Bargaining Power Among Buyers
    2. INDUSTRY VALUE CHAIN ANALYSIS
    3. MARKET DYNAMICS
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
    4. MARKET TREND ANALYSIS
    5. REGULATORY LANDSCAPE
    6. PESTLE ANALYSIS
    7. PRICE TREND ANALYSIS
    8. PATENT ANALYSIS
    9. TECHNOLOGY EVALUATION
    10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR
      1. Geopolitical Market Disruptions
      2. Supply Chain Disruptions
      3. Instability in Emerging Markets
    11. ECOSYSTEM
  6. SLEEP APNEA DEVICES MARKET BY TYPE (2017-2032)
    1. SLEEP APNEA DEVICES MARKET SNAPSHOT AND GROWTH ENGINE
    2. MARKET OVERVIEW
    3. OBSTRUCTIVE SLEEP APNEA
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017-2032F)
      3. Historic And Forecasted Market Size in Volume (2017-2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
    4. CENTRAL SLEEP APNEA
    5. COMPLEX SLEEP APNEA
  7. SLEEP APNEA DEVICES MARKET BY TREATMENT (2017-2032)
    1. SLEEP APNEA DEVICES MARKET SNAPSHOT AND GROWTH ENGINE
    2. MARKET OVERVIEW
    3. CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP)
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017-2032F)
      3. Historic And Forecasted Market Size in Volume (2017-2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
    4. SURGERY
    5. ORAL APPLICATIONS
    6. MEDICATIONS
  8. SLEEP APNEA DEVICES MARKET BY END-USER (2017-2032)
    1. SLEEP APNEA DEVICES MARKET SNAPSHOT AND GROWTH ENGINE
    2. MARKET OVERVIEW
    3. HOSPITALS/CLINICS
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017-2032F)
      3. Historic And Forecasted Market Size in Volume (2017-2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
    4. AMBULATORY CARE CENTRE
    5. DIAGNOSTIC CENTRES
    6. SPECIALTY CARE CENTRES
    7. HOME HEALTHCARE
  9. COMPANY PROFILES AND COMPETITIVE ANALYSIS
    1. COMPETITIVE LANDSCAPE
      1. Competitive Benchmarking
      2. SLEEP APNEA DEVICES Market Share By Manufacturer (2023)
      3. Industry BCG Matrix
      4. Heat Map Analysis
      5. Mergers & Acquisitions
    2. RESPIRONICS (UNITED STATES)
      1. Company Overview
      2. Key Executives
      3. Company Snapshot
      4. Role of the Company in the Market
      5. Sustainability and Social Responsibility
      6. Operating Business Segments
      7. Product Portfolio
      8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
      9. Key Strategic Moves And Recent Developments
      10. SWOT Analysis
    3. FISHER & PAYKEL HEALTHCARE (NEW ZEALAND)
    4. DEVILBISS HEALTHCARE (UNITED STATES)
    5. KONINKLIJKE PHILIPS (NETHERLANDS)
    6. RESMED (UNITED STATES)
    7. OVENTUS (AUSTRALIA)
    8. SOMNOMED (AUSTRALIA)
    9. VIVOS THERAPEUTICS (UNITED STATES)
    10. WHOLEYOU (UNITED STATES)
    11. BMC MEDICAL CO., LTD. (CHINA)
    12. WEINMANN MEDICAL TECHNOLOGY (GERMANY)
    13. APEX MEDICAL CORP. (TAIWAN)
    14. COMPUMEDICS LIMITED (AUSTRALIA)
    15. BRAEBON MEDICAL CORPORATION (CANADA)
    16. CADWELL INDUSTRIES, INC. (UNITED STATES)
    17. IMTHERA MEDICAL (UNITED STATES)
    18. INSPIRE MEDICAL SYSTEMS (UNITED STATES)
    19. LÖWENSTEIN MEDICAL (GERMANY)
    20. NIHON KOHDEN CORPORATION (JAPAN)
    21. ITAMAR MEDICAL LTD. (ISRAEL)
    22. TELEFLEX INCORPORATED (UNITED STATES)
    23. VYAIRE MEDICAL (UNITED STATES)
    24. CIRCADIANCE (UNITED STATES)
    25. AIRING (UNITED STATES)
    26. SLEEPNET CORPORATION (UNITED STATES)
    27. ZEPHYR SLEEP TECHNOLOGIES (CANADA)
    28. OVENTUS MEDICAL (AUSTRALIA)
    29. AIRWAY MANAGEMENT INC. (UNITED STATES)
    30. PROVENT SLEEP THERAPY (UNITED STATES)
    31. NIGHTBALANCE (NETHERLANDS)
    32. SEFAM GROUP (FRANCE)
  10. GLOBAL SLEEP APNEA DEVICES MARKET BY REGION
    1. OVERVIEW
    2. NORTH AMERICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By TYPE
      4. Historic And Forecasted Market Size By TREATMENT
      5. Historic And Forecasted Market Size By END-USER
      6. Historic And Forecasted Market Size By Country
        1. USA
        2. Canada
        3. Mexico
    3. EASTERN EUROPE
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
        1. Russia
        2. Bulgaria
        3. The Czech Republic
        4. Hungary
        5. Poland
        6. Romania
        7. Rest Of Eastern Europe
    4. WESTERN EUROPE
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
        1. Germany
        2. United Kingdom
        3. France
        4. The Netherlands
        5. Italy
        6. Spain
        7. Rest Of Western Europe
    5. ASIA PACIFIC
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Malaysia
        6. Thailand
        7. Vietnam
        8. The Philippines
        9. Australia
        10. New-Zealand
        11. Rest Of APAC
    6. MIDDLE EAST & AFRICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
        1. Turkey
        2. Bahrain
        3. Kuwait
        4. Saudi Arabia
        5. Qatar
        6. UAE
        7. Israel
        8. South Africa
    7. SOUTH AMERICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
  11. INVESTMENT ANALYSIS
  12. ANALYST VIEWPOINT AND CONCLUSION
    1. Recommendations and Concluding Analysis
    2. Potential Market Strategies

Global Sleep Apnea Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017-2023

Market Size In 2023:

USD 5.9 Bn

Forecast Period 2024-32 CAGR:

6.53%

Market Size In 2032:

USD 10.43 Bn

Segments Covered:

By Type

  • Obstructive Sleep Apnea
  • Central Sleep Apnea
  • Complex Sleep Apnea

By Treatment

  • CPAP
  • Surgery
  • Oral Applications
  • Medications

By End-User

  • Hospitals/Clinics
  • Ambulatory Care Centre
  • Diagnostic Centres
  • Specialty Care Centres
  • Home Healthcare

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest Of Eastern Europe)
  • Western Europe (Germany, Uk, France, Netherlands, Italy, Russia, Spain, Rest Of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest Of Apac)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, Uae, Israel, South Africa)
  • South America (Brazil, Argentina, Rest Of Sa)

Key Market Drivers:

  • Growing Demand for Efficient Treatment Alternatives

Key Market Restraints:

  • Affordability Concern for Expensive Healthcare Devices

Key Opportunities:

  • Shift Toward Home-Based Sleep Testing and Treatment

Companies Covered In The Report:

  • Resmed, Philips, Respironics, Oventus, And Other Major Players
Please Wait...

Frequently Asked Questions :

What would be the forecast period in the Sleep Apnea Devices Market research report?

The forecast period in the Sleep Apnea Devices Market research report is 2024-2032.

Who are the key players in the Sleep Apnea Devices Market?

Respironics (United States),Fisher & Paykel Healthcare (New Zealand),DeVilbiss Healthcare (United States), Koninklijke Philips (Netherlands),ResMed (United States), Oventus (Australia), SomnoMed (Australia), Vivos Therapeutics (United States), WholeYou (United States),BMC Medical Co., Ltd. (China),Weinmann Medical Technology (Germany),Apex Medical Corp. (Taiwan), Compumedics Limited (Australia),Braebon Medical Corporation (Canada),Cadwell Industries, Inc. (United States), ImThera Medical (United States),Inspire Medical Systems (United States),Löwenstein Medical (Germany), Nihon Kohden Corporation (Japan),Itamar Medical Ltd. (Israel),Teleflex Incorporated (United States), Vyaire Medical (United States), Circadiance (United States),Airing (United States), Sleepnet Corporation (United States), Zephyr Sleep Technologies (Canada), Oventus Medical (Australia),Airway Management Inc. (United States),Provent Sleep Therapy (United States), NightBalance (Netherlands), Sefam Group (France) and Other Major Players.

What are the segments of the Sleep Apnea Devices Market?

The Sleep Apnea Devices Market is segmented into Type, treatment, end used, and region. By Type (Obstructive, Central, and Complex Sleep Apnea), By Treatment (CPAP, Surgery, Oral Appliances, Medications), and By End-User (Hospital/Clinics, Ambulatory Care Centres, Diagnostic Centres, Specialty Care Centres, Home Healthcare). By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).

What is the Sleep Apnea Devices Market?

Sleep apnea is a condition occurring during sleep characterized by repeated pauses in breathing, shallow breathing episodes, or the obstruction of the upper airway, leading to inadequate ventilation and disturbances in sleep patterns.

How big is the Sleep Apnea Devices Market?

The global Sleep Apnea Devices Market was valued at USD 5.9 billion in 2023 and is likely to reach USD 10.43 billion by 2032, increasing at a CAGR of 6.53% from 2024 to 2032.